We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+11.11%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$218B
AUM Growth
-$5.41B
Cap. Flow
-$25.1B
Cap. Flow %
-11.51%
Top 10 Hldgs %
47.1%
Holding
5,603
New
345
Increased
2,379
Reduced
1,667
Closed
541

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.82B
2
AAPL icon
Apple
AAPL
+$1.62B
3
UNH icon
UnitedHealth
UNH
+$1.03B
4
XOM icon
ExxonMobil
XOM
+$869M
5
TSLA icon
Tesla
TSLA
+$701M

Sector Composition

Rank Sector Weight
1 Technology 12.19%
2 Consumer Discretionary 5.03%
3 Healthcare 4.78%
4 Financials 4.74%
5 Communication Services 2.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGU icon
4651
Star Group
SGU
$412M
$4.47K ﹤0.01%
345
SUNL
4652
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
$4.38K ﹤0.01%
702
+381
+119% +$8.39K
ERIC icon
4653
Ericsson
ERIC
$32.2B
$4.33K ﹤0.01%
740
-145
-16% -$827
SLGN icon
4654
Silgan Holdings
SLGN
$4.23B
$4.29K ﹤0.01%
80
VIRX
4655
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$4.24K ﹤0.01%
2,668
-83
-3% -$151
SBFG icon
4656
SB Financial Group
SBFG
$164M
$4.22K ﹤0.01%
299
GOTU icon
4657
Gaotu Techedu
GOTU
$434M
$4.22K ﹤0.01%
1,000
PLX icon
4658
Protalix BioTherapeutics
PLX
$191M
$4.2K ﹤0.01%
2,000
PLG
4659
Platinum Group Metals
PLG
$164M
$4.15K ﹤0.01%
2,900
MERC icon
4660
Mercer International
MERC
$42.3M
$4.14K ﹤0.01%
424
-8,258
-95% -$93.1K
BYNO
4661
DELISTED
byNordic Acquisition Corporation Class A Common Stock
BYNO
$4.14K ﹤0.01%
400
CVE.WS
4662
DELISTED
Cenovus Energy Inc Warrants
CVE.WS
$4.11K ﹤0.01%
331
XPH icon
4663
State Street SPDR S&P Pharmaceuticals ETF
XPH
$476M
$4.1K ﹤0.01%
100
VIP
4664
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$38.1M
$3.86K ﹤0.01%
853
+467
+121% +$2.82K
NGNE icon
4665
Neurogene
NGNE
$656M
$3.7K ﹤0.01%
265
-22,348
-99% -$262K
ENLV icon
4666
Enlivex Ltd
ENLV
$35.2M
$3.64K ﹤0.01%
67
NOK icon
4667
Nokia
NOK
$51B
$3.63K ﹤0.01%
740
-32
-4% -$151
LGHL
4668
Lion Group Holding
LGHL
$853K
0
XENE icon
4669
Xenon Pharmaceuticals
XENE
$6.06B
$3.58K ﹤0.01%
+100
New +$3.69K
TMBR
4670
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$3.52K ﹤0.01%
2,072
DVYA icon
4671
iShares Asia/Pacific Dividend ETF
DVYA
$71.6M
$3.32K ﹤0.01%
98
ONCR
4672
DELISTED
Oncorus, Inc.
ONCR
$3.27K ﹤0.01%
9,495
AMTI
4673
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$3.25K ﹤0.01%
10,154
PFSI icon
4674
PennyMac Financial
PFSI
$3.92B
$3.1K ﹤0.01%
52
-25
-32% -$1.55K
EXAI
4675
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$3.06K ﹤0.01%
+578
New +$3.92K

Similar funds

Barclays's Q1 2023 Portfolio in Review

As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.

  • Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
  • Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
  • Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
  • Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
  • Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
  • Barclays opened 345 new positions and closed 541 in Q1 2023.
  • Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.

Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.